Compare Nuvalent Inc (NUVL) vs SOLAI Limited (SLAI) Price & Performance

Nuvalent IncTrade

SOLAI LimitedTrade

Price performance (Past 24H)

Key statistics

Nuvalent Inc vs SOLAI Limited — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while SOLAI Limited trades at $3.72 (market cap $16.69M). The key difference: Nuvalent Inc is far larger — about 587.8× SOLAI Limited's market cap, and Nuvalent Inc is trading nearer its 52-week high, SOLAI Limited nearer its low. Which is the better fit depends on your goals.

	NUVL	SLAI
Market Cap	$9.81B	$16.69M
Sector	Technology	Technology
52-Week High	$123.96	$26.74
52-Week Low	$72.16	$2.74
Enterprise Value	$8.52B	$16.33M

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

NUVL

Brodsky & Smith investigates fiduciary duty breaches in multiple major merger deals.GlobeNewsWire · 11 hours agoBearish View details →

SLAI

SOLAI Limited to be delisted from NYSE due to low market cap, plans OTC market listing.PRNewsWire · 16 hours agoBearish View details →

About Nuvalent Inc

Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.

About SOLAI Limited

SOLAI focuses on providing innovative AI-driven software solutions. The company leverages artificial intelligence to enhance digital experiences and optimize business processes for various industries.